The factsheet has been successfully sent.
Please check your inbox.
Please fill in the form to receive the factsheet directly into your inbox

You have items in your inquiry list.
Inquire now?

30 May 2023 [Press release]

New study uses GenoFlow™ STD Array Test Kit to uncover misdiagnosis of sexually transmitted diseases in Hong Kong outpatient healthcare

A new Hong Kong study1 shows the importance of multiplex testing, in order to avoid misdiagnosis of sexually transmitted diseases (STDs). Incorrect test selection made by physicians was one of the major reasons for STD misdiagnosis in outpatient settings.

To reduce errors in STD diagnosis, physicians are encouraged to select and request a test that allows detection of multiple pathogens, as co-infection of multiple pathogens in STD patients is commonly observed. A test such as DiagCor Life Science's GenoFlow™ STD Array Test Kit is ideal for these purposes. 

Continued medical education is needed globally to highlight the importance and benefits of the GenoFlow™ STD Array Test Kit and other multiplex tests, for more improved patient and public health outcomes.

1Lau A, Ho D (2023). Misdiagnosis of Sexually Transmitted Diseases in Hong Kong Outpatient Private Healthcare. Open Journal of Medical Microbiology. 13:31-42.


About DiagCor

Headquartered in Hong Kong with ISO 13485 accredited Quality Management System, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, DiagCor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.

Press Contact

DiagCor Life Science

[email protected]